Condition: Center Involved Diabetic Macular Edema · Diabetic Macular Edema · Sponsor: Ocugen
A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema
This description comes directly from the study's public registry record.
Roshan A George, MD, MPH · 845-664-1505 · roshan.george@ocugen.com
Oscar Cuzzani, MD, PhD · Oscar.Cuzzani@ocugen.com
Always discuss trial participation with your own doctor first.
| Advanced Research LLC | Deerfield Beach, Florida, United States | Recruiting |
| Erie Retina Research, LLC | Erie, Pennsylvania, United States | Recruiting |
| Retina Consultants of Texas Research Centers | Bellaire, Texas, United States | Recruiting |
| Retina Consultants of America | Southlake, Texas, United States | Recruiting |
| Gundersen Health System | La Crosse, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05802329